Læknablaðið

Árgangur

Læknablaðið - 15.07.1958, Síða 3

Læknablaðið - 15.07.1958, Síða 3
LÆKNABLAÐIÐ an important new use for a remarkable new drug AT LAST... A KEYSTONE IN THE THERAPY OFALL HYPERTENSIVE PATIENTS Originally developed as an oral diuretic—with effectiveness comparable to that of parenteral mercurials—further extensive dinical research has shown CHLOTRIDE to possess the following unique advantages in the therapy of hypertension: potentiates the action of reserpine. Veratrum, hydralazine, and ganglionic blocking agents such as MEVASINE* / permits reduced dosage of these drugs and, therefore, lower incidence of side effects / enhances the effects ot splanchmcectomy / simplifies dosage regimens / may permit more liberal dietary salt intake / virtually nontoxic • ICMLOMOTHI&IIOI I MBRCK SHARP OIVISION OF MERCK & CO.. Inc & DOHME INTERNATIONAL 1 61 AVCNUE Op Th| AMIRICAS, N|W VORK 13. N|W VORK. O. S. A. CL.T-J53E.-(C)

x

Læknablaðið

Beinleiðis leinki

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Læknablaðið
https://timarit.is/publication/986

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.